BioSystem Engineering (01355.HK) plans to conduct a rights issue based on a "2 shares for 1" ratio, with a maximum net fundraising of approximately HKD 39 million.

The Zhitong Financial News app reported that BioSyst Eng (01355.HK) issued an announcement, suggesting that based on the announcement date, 1.193 billion shares have been issued, and for every 2 existing shares held on the record date, 1 share of rights shares will be issued at a subscription price of 0.068 Hong Kong dollars per rights share. Assuming that there is no change in the total number of shares issued from the announcement date to the record date (including the same day), the company will issue up to 596.5 million rights shares, raising approximately 40 million Hong Kong dollars (before expenses). After deducting estimated expenses related to the rights issue, the estimated net proceeds from the rights issue will be approximately 39 million Hong Kong dollars.